Bill · HR
H.R. 5160 (119th)
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Original
Introduced
4 September 2025
Last action
21 July 2026 · Introduced
Status
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.
Sponsors
Rep. Smith, Christopher H. [R-NJ-4], Doris Matsui, Rep. Bilirakis, Gus M. [R-FL-12], Chellie Pingree, Rep. Tenney, Claudia [R-NY-24], Kweisi Mfume, Rep. Fischbach, Michelle [R-MN-7], Debbie Dingell, Rep. Gottheimer, Josh [D-NJ-5], Rep. Aderholt, Robert B. [R-AL-4], Rep. Malliotakis, Nicole [R-NY-11], Kathy Castor, Andrew Garbarino, Del. Norton, Eleanor Holmes [D-DC-At Large], Cliff Bentz, Nanette Barragán, Rep. Finstad, Brad [R-MN-1], Kelly Morrison, Rep. Lawler, Michael [R-NY-17], Rep. Vindman, Eugene Simon [D-VA-7], Rep. Fitzpatrick, Brian K. [R-PA-1], Sharice Davids
Subjects
Healthcare
Source updated
26 August 2026
Summary
Stem Cell Therapeutic and Research Reauthorization Act of 2025 This bill reauthorizes through FY2031 and revises programs that help patients receive transplants of bone marrow or umbilical cord blood from biologically unrelated donors. These programs are administered by the Health Resources and Services Administration (HRSA). The bill reauthorizes the C.W. Bill Young Cell Transplantation Program. This program supports transplantation of bone marrow and cord blood by increasing the quantities of donations, providing processes for matching and distributing donated materials to patients, and providing related information and research. Also, the bill reauthorizes and revises the National Cord Blood Inventory program, through which HRSA contracts with qualified cord blood banks to collect and maintain a supply of high-quality units for transplantation through the C.W. Bill Young Cell Transplantation Program. The bill amends the inventory program by (1) changing the inventory goal from 150,000 units to a sufficient supply as determined by HRSA, (2) requiring HRSA to manage the size and composition of the inventory to maximize clinical utility and efficiency, and (3) defining high quality cord blood unit to mean a unit meeting current industry standards and the requirements of the Food and Drug Administration.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
4 September 2025
Introduced
Introduced in House
Source: IntroReferral
4 September 2025
Referred
Referred to the Subcommittee on Health.
Source: Committee
4 September 2025
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
4 September 2025
Introduced
Introduced in House
Source: IntroReferral
13 May 2026
Committee
Forwarded by Subcommittee to Full Committee by Voice Vote.
Source: Committee
13 May 2026
Committee
Subcommittee Consideration and Mark-up Session Held
Source: Committee
21 May 2026
Vote
Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
Source: Committee
21 May 2026
Committee
Committee Consideration and Mark-up Session Held
Source: Committee
2 July 2026
Calendars
Placed on the Union Calendar, Calendar No. 629.
Source: Calendars
2 July 2026
Reported
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.
Source: Committee
2 July 2026
Reported
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.
Source: Committee
20 July 2026
Passed
Motion to reconsider laid on the table Agreed to without objection.
Source: Floor
20 July 2026
Passed
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)
Source: Floor
20 July 2026
Passed
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)
Source: Floor
20 July 2026
Floor
DEBATE - The House proceeded with forty minutes of debate on H.R. 5160.
Source: Floor
20 July 2026
Floor
Considered under suspension of the rules. (consideration: CR H4642-4643)
Source: Floor
20 July 2026
Floor
Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
Source: Floor
21 July 2026
Introduced
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.
Source: Calendars
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
5 official files
Placed on Calendar Senate
Placed on Calendar Senate · EN · 21 July 2026
Engrossed in House
Engrossed in House · EN · 20 July 2026
Reported in House
Reported in House · EN · 2 July 2026
Reported to House
summary · EN · 2 July 2026
Introduced in House
Introduced in House · EN · 4 September 2025
Sponsors
- Rep. Smith, Christopher H. [R-NJ-4] · R · Sponsor
- Doris Matsui · D · Sponsor
- Rep. Bilirakis, Gus M. [R-FL-12] · R · Sponsor
- Chellie Pingree · D · Sponsor
- Rep. Tenney, Claudia [R-NY-24] · R · Sponsor
- Kweisi Mfume · D · Sponsor
- Rep. Fischbach, Michelle [R-MN-7] · R · Cosponsor
- Debbie Dingell · D · Cosponsor
- Rep. Gottheimer, Josh [D-NJ-5] · D · Cosponsor
- Rep. Aderholt, Robert B. [R-AL-4] · R · Cosponsor
- Rep. Malliotakis, Nicole [R-NY-11] · R · Cosponsor
- Kathy Castor · D · Cosponsor
- Andrew Garbarino · R · Cosponsor
- Del. Norton, Eleanor Holmes [D-DC-At Large] · D · Cosponsor
- Cliff Bentz · R · Cosponsor
- Nanette Barragán · D · Cosponsor
- Rep. Finstad, Brad [R-MN-1] · R · Cosponsor
- Kelly Morrison · D · Cosponsor
- Rep. Lawler, Michael [R-NY-17] · R · Cosponsor
- Rep. Vindman, Eugene Simon [D-VA-7] · D · Cosponsor
- Rep. Fitzpatrick, Brian K. [R-PA-1] · R · Cosponsor
- Sharice Davids · D · Cosponsor
- · hsif00 · Standing
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/119th-congress/house-bill/5160
- Open data entity: https://api.congress.gov/v3/bill/119/hr/5160
- us · 119-hr-5160 · source updated 26 August 2026